[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.186.91. Please contact the publisher to request reinstatement.
Article
January 1940

TREATMENT OF MULTIPLE SCLEROSIS WITH NICOTINIC ACID AND VITAMIN B1: PRELIMINARY REPORT

Author Affiliations

PHILADELPHIA

From the Jewish Hospital and the John L. Eckel Neuropathological Laboratory, University of Pennsylvania Graduate School of Medicine.

Arch Intern Med (Chic). 1940;65(1):1-20. doi:10.1001/archinte.1940.00190070011001
Abstract

The treatment of advanced multiple sclerosis with nicotinic acid and a combination of nicotinic acid and thiamin chloride has yielded promising results in cases in which the patients have failed to respond to therapies hitherto used. While complete remission has not been obtained, the use of the treatment suggested here has resulted in continued symptomatic improvement. The potential value of the suggested treatment may be judged in the light of prevailing conceptions of the etiology and treatment of multiple sclerosis.

From 1838, when Sir Robert Carswell, as cited by Putnam,1 first described the pathology of multiple sclerosis, up to the present, the treatment of this disease has been entirely empiric. When one examines the diversity of remedial agents and methods employed, it becomes evident that the disarray is occasioned by complete ignorance of the etiology of the disease, coupled with the desire to find a remedy for one of the

×